What's breaking now, across thousands of outlets.
Two years after GSK announced its first licensing deal with Chimagen Biosciences, the UK drugmaker is making a new deal with the Chinese company for a trispecific T cell engager that it ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Final results from the landmark PAPILLON trial, which changed the standard of care for a difficult-to-treat rare form of lung cancer, confirm that amivantamab, when added to chemotherapy, provides…
What else don't we know? Don't miss a story, subscribe here.
The Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, has said tax reforms and economic growth are critical to strengthening Nigeria’s health financing, noting that the country needs to…
[AIM] Maputo -- Lack of diversified diet affects 80 percent of Mozambican minors, contributing to micronutrient deficiencies as well as increasing the risk of malnutrition, according to the health…
Ghana has launched the Presidential Initiative on Maternal Health Emergency Response (PRIMER) to step up efforts to reduce maternal deaths and ensure women receive timely and quality care before…
